Cancer Research

In The Spotlight

DDNews Cancer Research Exclusive

Taking the fight straight to the source

(Photo credit: Stephan Lab / Fred Hutchinson Cancer Research Center)

Biomedical mesh loaded with T cells and implanted on tumors led to tumor clearance in mouse models, Fred Hutchinson team reports

NEWS

Special Report on Cancer: Anticipating antibodies
Digging deeper into repertoires means tapping into Plan B (cell)

Making a deal on ADCs
Trio Pharmaceuticals and Ajinomoto enter into development collaboration

Preclinical proof in print for BAY 1905254
Compugen Ltd. recently shared news of the publication of a peer-reviewed paper in Cancer Immunology Research regarding BAY 1905254, which is an immune checkpoint inhibitor of the immunoglobulin-like domain containing receptor 2

Focus Feature on Cancer Research News
Recent happenings on the R&D front to better understand cancer and create oncology therapeutics

A bountiful B-round for BNCT
TAE Life Sciences secures $30 million in initial B round funds

Well-tolerated tumor drug
Antibody therapeutic from Compugen demonstrates no dose-limiting toxicities

More skin in the game
Libtayo shows promise for a second indication

Exercising the option
Bold Therapeutics and Hana Pharm execute option for exclusive development and commercialization rights to BOLD-100 in South Korea

FEATURES

Focus Feature On Cancer Research News:

Cancer therapies and insights up top

A roundup of recent research and development efforts in brain and lung cancers

OPINION

Guest Commentary: ACT clinical trials--The long road

by Martin Lachs/Brandon Fletcher

As excitement and investment related to adoptive cell transfer products increases, there are concerns and issues that need to be addressed in terms of long-term follow-up trials

Open Science approaches to the treatment of a rare childhood cancer

by Sue Cramp, Charles River

In pursuit of new options for treating childhood cancers, a new approach to drug discovery and development may be an answer

Guest Commentary: The growing potential of CAR T-cell therapy

by Andrea Toell of Lonza

Andrea Toell of Lonza shares how CAR T cells are transforming immuno-oncology

PAGE UTILITIES

	PRINT CURRENT PAGE
	SEND THIS PAGE TO A COLLEAGUE

DDNEWS

478 Bay Street, Suite A213

Midland, Ontario, Canada L4R 1K9

Ph: 888-781-0328 | Fax: 705-528-0270